Trek.pub Trekking around the net
Related Articles
On Monday, President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. claimed that Tylenol use during pregnancy and folate deficiency might contribute to autism, despite widespread dissent among scientific and health organizations. This announcement aligns with Kennedy’s longstanding anti-vaccine stance and criticism of the pharmaceutical industry. Autism is currently diagnosed in 1 in 31 children, with symptoms highly variable in severity. Kennedy has previously described autistic individuals as societal burdens and has often associated vaccines with autism, a claim unsupported by credible research.
During the press conference, Trump made several incoherent remarks about the supposed links between medication, vaccines, and autism. He questioned the need for vaccinations in infants and suggested delaying the Hepatitis B vaccine, displaying a misunderstanding of its importance. Trump also hinted at a new autism treatment while simultaneously disparaging Tylenol.
Public health experts criticized the announcement, highlighting that credible research does not support a direct link between Tylenol and autism. Organizations like the American College of Obstetricians and Gynecologists described the statements as irresponsible. Despite Kennedy’s claims to advance autism research, his organization has a history of promoting conspiracy theories related to vaccines and environmental toxins.
Ultimately, the CDC and other authorities reaffirmed that autism is likely influenced by a blend of genetic and environmental factors, dismissing simple causative explanations as misleading.
Read this related Trek here:
The Bonkers Wellness Myths That Fueled Trump’s Autism Announcement
